Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
As of close of business last night, Cogent Biosciences Inc’s stock clocked out at $9.25, up 2.89% from its previous closing price of $8.99. In other words, the price has increased by $2.89 from its previous closing price. On the day, 0.99 million shares were traded.
Ratios:
To gain a deeper understanding of COGT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.44 and its Current Ratio is at 6.44. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.
On February 26, 2024, Robert W. Baird Downgraded its rating to Neutral which previously was Outperform and also lowered its target price recommendation from $14 to $8.
On February 08, 2024, Citigroup started tracking the stock assigning a Buy rating and target price of $11.Citigroup initiated its Buy rating on February 08, 2024, with a $11 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 14 ’25 when Pinnow Cole bought 43,750 shares for $7.60 per share. The transaction valued at 332,412 led to the insider holds 45,848 shares of the business.
Stock Price History:
Over the past 52 weeks, COGT has reached a high of $12.61, while it has fallen to a 52-week low of $4.62. The 50-Day Moving Average of the stock is 8.34%, while the 200-Day Moving Average is calculated to be 0.73%.
Shares Statistics:
A total of 110.46M shares are outstanding, with a floating share count of 88.88M. Insiders hold about 19.54% of the company’s shares, while institutions hold 92.19% stake in the company.
